Narine

Quick links to important sections

Narine

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Narine

Property Description
Active Ingredients Loratadine and Pseudoephedrine
Form Oral Tablet (Fixed-Dose Combination)
Pharmacological Class Antihistamine-Decongestant Combination
Common Use Symptomatic relief of allergy and congestion
Origin Synthetic Compounds

Narine is a synthetic pharmaceutical preparation defined as a fixed-dose combination (FDC) medicine, categorized as an Antihistamine-Decongestant combination. This product is widely recognized in the medical community for its dual-action formula and is designed for oral route administration, typically presented as a tablet. This dual approach makes it a clinically recognized solution for treating the combined symptoms of allergy and congestion, which single-agent drugs cannot fully address.

Active Composition and Differentiation

The foundation of Narine lies in the specific co-formulation of two active ingredients: Loratadine and Pseudoephedrine, the latter commonly present as Pseudoephedrine HCl. Loratadine is characterized as a second-generation H1-receptor antagonist, which distinguishes it from older compounds by its lower propensity for causing sedation. Pseudoephedrine is a sympathomimetic amine that acts as a systemic decongestant. Pharmacological studies have consistently supported the efficacy of this combination, confirming its value in providing robust symptomatic relief.

General Purpose

The overall purpose of this FDC is to provide efficient and combined relief for upper respiratory symptoms that involve both allergy and physical obstruction. This synergistic strategy, encompassing both allergic symptom blockade and physical nasal passage clearing, is a standard approach recommended by healthcare professionals for comprehensive relief from conditions like persistent hay fever involving nasal congestion.

Regulatory References

  1. Pseudoephedrine
  2. Synthetic Organic Compound
  3. Oral Administration
  4. Tablet Dosage Form
  5. Symptomatic Treatment

What side effects are possible with Narine?

Possible Side Effects and Safety Information

The safety profile of Narine, a fixed-dose combination of loratadine and pseudoephedrine, is officially defined by government regulatory documents based on classified frequency and system-organ effects. The adverse reactions are grouped into categories established through clinical trials and post-marketing surveillance.

Classification Examples of Documented Effects
Very Common/Common Insomnia (difficulty sleeping), headache, dizziness, drowsiness, dry mouth, nervousness, tiredness, fast heartbeat (tachycardia).
Uncommon Palpitations, confusion, tremor, frequent or abnormal urination.
Very Rare Severe allergic reactions (anaphylaxis), convulsions, abnormal liver function, psychotic states, and severe skin reactions like Acute Generalized Exanthematous Pustulosis (AGEP).

Serious adverse reactions documented in regulatory sources include signs of severe allergic response and the potential for severe cardiovascular events. The effects are primarily observed in the Nervous System (e.g., stimulation, sleep disturbance), Cardiac/Vascular Disorders, and the Gastrointestinal System.

Population-Specific Safety Considerations

The official labeling notes that older adults may be more sensitive to effects such as dizziness, confusion, and urinary retention. For individuals with severe renal or hepatic impairment, the elimination of the active components may be altered. The use of the medicine during pregnancy and lactation is generally not recommended as the components are excreted in breast milk and safety has not been fully established. Safety and efficacy have not been established in children younger than 12 years of age.

Safety-Related Restrictions and Limitations

Use is prohibited in patients with pre-existing conditions such as severe hypertension, severe coronary artery disease, narrow-angle glaucoma, and documented urinary retention. The product is also contraindicated for use concurrently with, or within 14 days of stopping, Monoamine Oxidase Inhibitors (MAOIs) due to the risk of critical hypertensive reactions.

Overdose and Emergency Response

The official regulatory documents define the overdose profile of this combination product based on the effects of both the antihistamine (Loratadine) and the sympathomimetic (Pseudoephedrine) components. Documented overdose manifestations include cardiovascular effects such as Tachycardia and Palpitations, alongside neurological presentations of Somnolence, Headache, Dizziness, Restlessness, and Tremor.

More severe, life-threatening outcomes formally noted in official labeling include Hypertensive Crisis, Cardiac Arrhythmias, and Seizures. Significant overexposure may also result in profound CNS Depression or Psychotic Symptoms.

Upon suspected or confirmed overexposure, official guidance mandates that patients Seek immediate medical attention. Contact emergency services is required for severe or life-threatening symptoms, particularly those involving cardiovascular or significant CNS instability. The recommended management is Symptomatic and supportive treatment. No specific antidote is known for the Loratadine component.

Gastric lavage or administration of Activated charcoal slurry may be considered to reduce systemic absorption. Cardiac monitoring and extended hospital observation are required due to the risk of cardiovascular toxicity. Regulatory documents note that Children are more susceptible to excitatory CNS effects, while Elderly Patients may have increased sensitivity to cardiovascular effects.

Therapeutic Uses of Narine

What Narine Treats: Main Uses and Benefits

The primary therapeutic use of this preparation is to provide supportive relief for symptoms related to systemic imbalance, particularly within the digestive system. It is commonly applied in scenarios where additional management of discomfort and functional stability is needed. This product is considered relevant in contexts that involve supporting gastrointestinal health and promoting a balanced gut flora.


Support for Digestive Comfort and Stability

This preparation is applied in clinical settings marked by temporary physiological imbalance and may assist with managing symptom clusters that create noticeable functional strain. It may contribute to improved comfort during symptomatic periods and generally offers symptomatic relief that helps patients cope more steadily with difficult episodes. It is relevant for managing symptoms related to physical discomfort, such as occasional gas, bloating, and minor irregularity.

General Systemic Support

It is used for managing symptoms related to periods of increased physiological stress and is commonly used across conditions involving episodic or fluctuating manifestations, including recovery after antibiotic use or significant illness. It may assist with maintaining functional stability and contributes to easing the overall symptom load.

“It supports patients during difficult episodes by easing distress and assists with maintaining functional stability.”

Quick Fact: Focus on Easing Symptom Clusters

Eligibility and Restrictions for Use

Narine is a probiotic supplement containing the bacterial strain Lactobacillus acidophilus Er-2 strain 317/402, which is generally considered safe for use by a wide population, including healthy adults and children. It is often regarded as a "Generally Recognized as Safe (GRAS)" microorganism.


Potential Users

Narine has been historically used as a nourishing food supplement, and its use is typically supported for:

  • Adults and Children
  • Individuals during and after antibiotic therapy to help restore gut microbiota balance.
  • Those seeking to support general digestive health or in cases of gastrointestinal upset.

Contraindications and Precautions

As with most probiotics, there are specific situations where use requires caution or is not recommended. It is essential to consult a healthcare provider before starting Narine, especially for individuals with:

  • Severe Immunosuppression: This includes patients undergoing intensive chemotherapy, those with advanced HIV, or other conditions that severely compromise the immune system, due to a theoretical increased risk of infection.
  • Critical Illness: Individuals with conditions such as severe acute pancreatitis or those with a central venous catheter should avoid probiotics unless medically supervised.
  • Known Allergies to any components of the supplement, such as ingredients in the capsule or carrier medium.

While evidence is often inconclusive, pregnant or breastfeeding women should also seek medical advice before use.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official regulatory profile identifies several documented interaction patterns that impose specific administration constraints.

Interaction Classification and Restrictions

Co-administration is classified as contraindicated with two major substance categories. This includes Monoamine Oxidase Inhibitors (MAOIs), where an absolute restriction dictates the product must not be used concurrently or within a 14-day period after MAOI discontinuation due to the risk of severe hypertensive reactions. The combination is also strictly prohibited with certain Ergot Derivatives.

Pharmacokinetic and Pharmacodynamic Effects

  • Exposure Modification: Co-administration with potent CYP3A4/2D6 inhibitors, such as Ketoconazole and Erythromycin, leads to significantly increased plasma concentrations of Loratadine, a documented metabolic interaction.
  • Additive Effects: Combining with other Sympathomimetic Agents (e.g., other decongestants) may result in additive increases in blood pressure and heart rate. The official documents also note that Alcohol consumption may increase the severity of certain effects, such as drowsiness.
  • Absorption: Antacids increase the rate of Pseudoephedrine absorption, while Kaolin decreases it.

Population-Specific Note

Official labeling includes a specific caution for patients with severe hepatic or renal impairment, noting that a different dosage regimen is required due to altered drug clearance, which influences overall exposure and interaction potential.

Mechanism of Action

The mechanism of Narine centers on the RANKL-RANK pathway, a primary regulator of osteoclast formation and activity. Narine acts by specifically disrupting the molecular binding of RANKL (Receptor Activator of Nuclear Factor kappaB Ligand) to its receptor, RANK, which is expressed on the surface of pre-osteoclasts and mature osteoclasts.

This direct inhibition of the signaling cascade blocks the differentiation of pre-osteoclasts into mature, active osteoclasts. The resulting decrease in osteoclastogenesis and function leads to a reduction in bone resorption (bone lysis).

By reducing the rate of bone resorption, Narine modulates the physiological balance between bone breakdown and bone formation. This specific, targeted action results in a measurable decrease in serum bone turnover markers, reflecting a change in the cellular dynamics of bone remodeling.

Dosage and Administration Information

Administration Guidelines

Narine (Loratadine and Pseudoephedrine Fixed-Dose Combination) is for oral administration as an extended-release tablet. The method of administration is intended to maintain the drug’s intended time-release profile.

Dosage Formulation Standard Adult/Adolescent Dose (12 years) Maximum Dose (24 hours) Frequency
12-Hour Tablet (5 mg/120 mg) One tablet Two tablets Every 12 hours
24-Hour Tablet (10 mg/240 mg) One tablet One tablet Once daily

Procedural and Duration Constraints

The tablet must be swallowed whole with a full glass of water and must not be divided, crushed, chewed, or dissolved. Administration can occur with or without food. Use is restricted to individuals 12 years of age and older, as safety and efficacy have not been established in younger children.

Treatment is intended for short-term use, generally limited to a maximum of 7 days for self-medication. Special caution is required in patients with renal or hepatic impairment, where a healthcare professional may determine the necessity of a lower dose or alternative regimen. Additionally, it is standard to discontinue the medicine at least 48 hours before scheduled skin allergy tests to prevent potential interference with results.

Recent Clinical Evidence

Research evidence / Overview of studies for Narine

Evidence for Support of Digestive Comfort and Stability

Research for this preparation was evaluated in studies exploring how symptoms change over time for outcomes related to physical discomfort in the digestive system. Studies included randomized controlled trials (RCTs) and observational settings, applied in research contexts involving fluctuating or unstable symptoms such as occasional gas, bloating, and minor irregularity. Researchers monitored changes in patient-reported outcomes describing perceived discomfort and research examined alterations in the balance of the gut microflora.

Some studies reported patterns observed in the cohorts, describing shifts in the composition of gut bacteria following administration. For instance, in a limited study involving individuals with Familial Mediterranean Fever (FMF), findings described changes in the growth characteristics of commensal Escherichia coli isolates that were observed following the study period. Studies contribute to understanding symptom patterns, and evidence suggests outcomes related to systemic or functional imbalance may vary across different studies and individual patient characteristics. Results apply only to the specific populations studied.

Long-term outcomes are not fully established, and evidence is limited regarding the maintenance of functional stability over extended periods of time. While some trials described patterns observed, certainty remains low when attempting to generalize findings to all individuals experiencing routine digestive discomfort.

Evidence for Functional Stability After Systemic Imbalance

Research has explored the use of this preparation in scenarios involving temporary physiological imbalance, particularly for those recovering after a course of antibiotics. In these settings, studies monitored patient-reported outcomes describing perceived discomfort and research examined the composition of the gut microbiota. The research scenarios focused on episodes where symptoms become more noticeable, such as the outcomes related to systemic or functional imbalance that were evaluated in groups recovering from antibiotic therapy.

Studies reported measurements of changes in the abundance of specific types of bacteria in the gut, outcomes that were linked to functional imbalance in the studies. For the general category of probiotics, data show patterns related to examining the incidence of antibiotic-associated diarrhea. Studies explored the potential for this specific preparation to be relevant in this context. However, comparative evidence is lacking when assessing this preparation directly against other established strains in studies observing AAD-related outcomes.

What remains largely uncertain is the reliability of its action for outcomes related to systemic or functional imbalance in diverse populations following periods of physiological strain. The research does not determine whether an individual will respond similarly to the reported group patterns, and data are still emerging regarding its specific utility in these complex conditions.

Research Gaps and Uncertainty

The overall evidence quality varies across studies, leading to a categorization of the evidence level as Moderate for digestive comfort. The main gaps noted in the research are the variability in reported findings and the reliance on studies that sometimes involve small sample sizes or specialized patient populations.

Additionally, long-term effects on outcomes reflecting daily functioning or activity level are not fully established. There is limited information for long-term outcomes, and research is ongoing to assess whether the preparation influences functional stability beyond short observation periods. Research findings describe group patterns, which means research provides context but not individual predictions about their personal outcomes.

Key Studies & References

  1. Probiotics Natural Health Product Monograph (Health Canada)

Frequently Asked Questions (FAQ)

Common questions about Narine (FAQ)

Q: Is Narine something I have to take every day?

The official administration guidelines indicate that Narine is intended for short-term use, with official guidelines often limiting self-medication to a maximum of seven days. The product is characterized by a schedule of once or twice daily administration, depending on the extended-release formulation, as part of its defined daily dosing schedule. This schedule is based on the official instructions for use.


Q: Are there any foods or drinks I need to avoid while on Narine?

According to the official product information, taking this medicine with alcohol may increase the severity of some effects, such as drowsiness. Beyond this, the official administration instructions state that the medicine can be taken with or without food. Specific mandatory food avoidance is not detailed in the labeling.


Q: What is the difference between Narine and a supplement?

Narine is described in regulatory documents as a fixed-dose combination (FDC) medicine, which means it contains two active pharmaceutical ingredients: Loratadine and Pseudoephedrine. This classifies it as an Antihistamine-Decongestant product, designed to provide symptomatic relief for allergy and congestion, which differs from many dietary supplements.


Q: Can Narine cause any long-term health problems?

The official administration guidelines indicate that Narine is intended only for short-term use, often limited to a maximum of seven days for self-medication. Because of this short-term use profile, regulatory text states that long-term outcomes and effects are not fully established by current research.


Q: What happens if I miss a dose of Narine?

The official instruction for a missed dose is to administer it as soon as the lapse is remembered. However, to prevent excessive intake, regulatory information advises against doubling the dose, suggesting the missed dose may be skipped if it is near the time for the next scheduled dose. Detailed instructions are usually found in the patient information leaflet.


Q: Is there any research about Narine for [non-core use, e.g., energy]?

Official research evidence has been primarily evaluated for its application in outcomes related to digestive comfort and supporting functional stability after temporary physiological imbalance. The regulatory overview notes that evidence is limited for other long-term outcomes or specific effects on daily functioning.


Q: Does Narine interact with common over-the-counter pain relievers?

The official interaction profile specifically details risks when combining Narine with other Sympathomimetic Agents, such as other decongestants, due to the risk of additive effects like increased blood pressure. The regulatory documents do not provide specific official warnings regarding the co-administration of common non-sympathomimetic pain relievers.


Q: Do you need a prescription to get Narine?

Official administration guidelines mention a limit of seven days for self-medication in its labeling, which indicates the product is commonly available without a prescription (Over-The-Counter) in many regulatory markets. However, due to its component (pseudoephedrine), access may be restricted to behind-the-counter in some locations.


Q: Is Narine considered a Schedule drug or controlled substance?

Official regulatory labeling typically lists this combination as a non-scheduled human OTC drug (Over-The-Counter) in the United States. However, regulations regarding the decongestant component, pseudoephedrine, can vary, meaning local laws may impose purchasing restrictions on the product.


Q: Can Narine be taken with vitamins or herbal products?

The official regulatory profile identifies that certain non-drug substances, such as antacids or Kaolin, can affect the absorption of the active components. The information does not provide explicit regulatory instructions regarding the co-administration of general vitamins or a comprehensive list of herbal products.


Q: What are the main risks associated with Narine use?

According to official safety information, the main risks are related to severe cardiovascular events and the potential for serious allergic reactions. Use is specifically prohibited in patients with pre-existing conditions such as severe hypertension or coronary artery disease. The official documents also note common nervous system effects like sleep disturbance and nervousness.


Q: Does Narine have a black box warning?

The official product label does not contain a Black Box Warning, which is the most prominent safety warning mandated by the FDA. However, the label does include specific, strong warnings regarding documented severe adverse effects and contraindications for specific patient populations and co-administered substances.


Q: What should I do if a side effect feels severe?

Official labeling contains a requirement to discontinue use and seek advice if specific severe reactions, such as an allergic reaction or excessive nervousness, dizziness, or sleeplessness, occur. The information also notes that overdose is a scenario requiring immediate emergency medical attention.


Q: Is Narine a brand name or a generic name?

Narine is typically presented as a trade name for the combination of the two generic active ingredients: Loratadine and Pseudoephedrine. This means the active chemical substances are generic, but 'Narine' is the proprietary name under which the product is marketed.


Q: Is Narine used for preventative care?

Official documents list the common use of Narine as providing symptomatic relief for combined allergy and congestion. This is defined as a treatment for existing symptoms, and its intended purpose is not categorized as preventative care.


Q: Why is Narine only available by prescription?

Official labeling refers to a maximum of seven days of self-medication in certain jurisdictions, which suggests it is commonly available without a prescription (Over-The-Counter). However, due to its decongestant component, local regulations may impose restrictions on its purchase and availability.


Q: How is Narine eliminated from the body?

Official product information notes that the liver and kidneys are involved in the elimination of the active components from the body. This is confirmed by regulatory cautions requiring dosage adjustments for patients with severe hepatic (liver) or renal (kidney) impairment due to altered drug clearance.


Q: Why is it listed as a possible side effect that Narine causes [common but vague side effect]?

Side effects are included in the official labeling because they were observed during clinical trials or reported through post-marketing surveillance. The effects such as nervousness or fast heartbeat are attributed to the action of the pseudoephedrine component, which regulatory documents identify as a sympathomimetic agent.

How should Narine be stored and disposed of?

Storage Requirements

Narine (Loratadine and Pseudoephedrine Sulfate Extended-Release Tablets) must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F), with permitted excursions up to 30 C (86 F). The product must be protected from both light and excessive moisture and must not be frozen. It is required to keep the medicine in the original container, tightly closed, and it must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused Narine should be disposed of by following official guidance. The best method is to utilize a drug take-back program or consult a pharmacist for instructions. If these options are unavailable, the tablets can be disposed of in household trash by mixing them with an undesirable substance (such as used coffee grounds or dirt) and placing the mixture in a sealed bag or container to prevent access.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Narine found in:

A-Z Index: